Circulating T regulatory cells migration and phenotype in glioblastoma patients: An in vitro study

Chiara Vasco, Alessandra Canazza, Ambra Rizzo, Adele Mossa, Elena Corsini, Antonio Silvani, Laura Fariselli, Andrea Salmaggi, Emilio Ciusani

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM) is the most aggressive primary human brain tumor. The relatively high amount of T regulatory lymphocytes present in the tumor, contributes to the establishment of an immunosuppressive microenvironment. Samples of peripheral blood were collected from GBM patients and healthy controls and a purified population of Treg (CD4+/ CD25bright) was isolated using flow cytometric cell sorting. Treg migrating capacities toward human glioma cell line conditioned medium were evaluated through an in vitro migration test. Our data show that supernatants collected from GBM cell lines were more attractant to Treg when compared to complete standard medium. The addition of an anti-CCL2 antibody to conditioned medium decreased conditioned medium-depending Treg migration, suggesting that CCL2 (also known as Monocyte Chemoattractant Protein, MCP-1) is implicated in the process. The number of circulating CD4+/μL or Treg/μL was similar in GBM patients and controls. Specific Treg markers (FOXP3; CD127; Helios; GITR; CTLA4; CD95; CCR2, CCR4; CCR7) were screened in peripheral blood and no differences could be detected between the two populations. These data confirm that the tumor microenvironment is attractive to Treg, which tend to migrate toward the tumor region changing the immunological response. Though we provide evidence that CCL2 is implicated in Treg migration, other factors are needed as well to provide such effect.

Original languageEnglish
Pages (from-to)353-363
Number of pages11
JournalJournal of Neuro-Oncology
Volume115
Issue number3
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Glioblastoma
Cell Movement
Conditioned Culture Medium
Phenotype
Cell Line
Tumor Microenvironment
Chemokine CCL2
Regulatory T-Lymphocytes
Immunosuppressive Agents
Brain Neoplasms
Glioma
Population
Anti-Idiotypic Antibodies
Neoplasms
In Vitro Techniques

Keywords

  • CCL2
  • Glioblastoma multiforme
  • Irradiation
  • Treg

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Circulating T regulatory cells migration and phenotype in glioblastoma patients : An in vitro study. / Vasco, Chiara; Canazza, Alessandra; Rizzo, Ambra; Mossa, Adele; Corsini, Elena; Silvani, Antonio; Fariselli, Laura; Salmaggi, Andrea; Ciusani, Emilio.

In: Journal of Neuro-Oncology, Vol. 115, No. 3, 12.2013, p. 353-363.

Research output: Contribution to journalArticle

Vasco, Chiara ; Canazza, Alessandra ; Rizzo, Ambra ; Mossa, Adele ; Corsini, Elena ; Silvani, Antonio ; Fariselli, Laura ; Salmaggi, Andrea ; Ciusani, Emilio. / Circulating T regulatory cells migration and phenotype in glioblastoma patients : An in vitro study. In: Journal of Neuro-Oncology. 2013 ; Vol. 115, No. 3. pp. 353-363.
@article{447a9bac5f9f4f32a53906313985707a,
title = "Circulating T regulatory cells migration and phenotype in glioblastoma patients: An in vitro study",
abstract = "Glioblastoma multiforme (GBM) is the most aggressive primary human brain tumor. The relatively high amount of T regulatory lymphocytes present in the tumor, contributes to the establishment of an immunosuppressive microenvironment. Samples of peripheral blood were collected from GBM patients and healthy controls and a purified population of Treg (CD4+/ CD25bright) was isolated using flow cytometric cell sorting. Treg migrating capacities toward human glioma cell line conditioned medium were evaluated through an in vitro migration test. Our data show that supernatants collected from GBM cell lines were more attractant to Treg when compared to complete standard medium. The addition of an anti-CCL2 antibody to conditioned medium decreased conditioned medium-depending Treg migration, suggesting that CCL2 (also known as Monocyte Chemoattractant Protein, MCP-1) is implicated in the process. The number of circulating CD4+/μL or Treg/μL was similar in GBM patients and controls. Specific Treg markers (FOXP3; CD127; Helios; GITR; CTLA4; CD95; CCR2, CCR4; CCR7) were screened in peripheral blood and no differences could be detected between the two populations. These data confirm that the tumor microenvironment is attractive to Treg, which tend to migrate toward the tumor region changing the immunological response. Though we provide evidence that CCL2 is implicated in Treg migration, other factors are needed as well to provide such effect.",
keywords = "CCL2, Glioblastoma multiforme, Irradiation, Treg",
author = "Chiara Vasco and Alessandra Canazza and Ambra Rizzo and Adele Mossa and Elena Corsini and Antonio Silvani and Laura Fariselli and Andrea Salmaggi and Emilio Ciusani",
year = "2013",
month = "12",
doi = "10.1007/s11060-013-1236-x",
language = "English",
volume = "115",
pages = "353--363",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "3",

}

TY - JOUR

T1 - Circulating T regulatory cells migration and phenotype in glioblastoma patients

T2 - An in vitro study

AU - Vasco, Chiara

AU - Canazza, Alessandra

AU - Rizzo, Ambra

AU - Mossa, Adele

AU - Corsini, Elena

AU - Silvani, Antonio

AU - Fariselli, Laura

AU - Salmaggi, Andrea

AU - Ciusani, Emilio

PY - 2013/12

Y1 - 2013/12

N2 - Glioblastoma multiforme (GBM) is the most aggressive primary human brain tumor. The relatively high amount of T regulatory lymphocytes present in the tumor, contributes to the establishment of an immunosuppressive microenvironment. Samples of peripheral blood were collected from GBM patients and healthy controls and a purified population of Treg (CD4+/ CD25bright) was isolated using flow cytometric cell sorting. Treg migrating capacities toward human glioma cell line conditioned medium were evaluated through an in vitro migration test. Our data show that supernatants collected from GBM cell lines were more attractant to Treg when compared to complete standard medium. The addition of an anti-CCL2 antibody to conditioned medium decreased conditioned medium-depending Treg migration, suggesting that CCL2 (also known as Monocyte Chemoattractant Protein, MCP-1) is implicated in the process. The number of circulating CD4+/μL or Treg/μL was similar in GBM patients and controls. Specific Treg markers (FOXP3; CD127; Helios; GITR; CTLA4; CD95; CCR2, CCR4; CCR7) were screened in peripheral blood and no differences could be detected between the two populations. These data confirm that the tumor microenvironment is attractive to Treg, which tend to migrate toward the tumor region changing the immunological response. Though we provide evidence that CCL2 is implicated in Treg migration, other factors are needed as well to provide such effect.

AB - Glioblastoma multiforme (GBM) is the most aggressive primary human brain tumor. The relatively high amount of T regulatory lymphocytes present in the tumor, contributes to the establishment of an immunosuppressive microenvironment. Samples of peripheral blood were collected from GBM patients and healthy controls and a purified population of Treg (CD4+/ CD25bright) was isolated using flow cytometric cell sorting. Treg migrating capacities toward human glioma cell line conditioned medium were evaluated through an in vitro migration test. Our data show that supernatants collected from GBM cell lines were more attractant to Treg when compared to complete standard medium. The addition of an anti-CCL2 antibody to conditioned medium decreased conditioned medium-depending Treg migration, suggesting that CCL2 (also known as Monocyte Chemoattractant Protein, MCP-1) is implicated in the process. The number of circulating CD4+/μL or Treg/μL was similar in GBM patients and controls. Specific Treg markers (FOXP3; CD127; Helios; GITR; CTLA4; CD95; CCR2, CCR4; CCR7) were screened in peripheral blood and no differences could be detected between the two populations. These data confirm that the tumor microenvironment is attractive to Treg, which tend to migrate toward the tumor region changing the immunological response. Though we provide evidence that CCL2 is implicated in Treg migration, other factors are needed as well to provide such effect.

KW - CCL2

KW - Glioblastoma multiforme

KW - Irradiation

KW - Treg

UR - http://www.scopus.com/inward/record.url?scp=84890254848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890254848&partnerID=8YFLogxK

U2 - 10.1007/s11060-013-1236-x

DO - 10.1007/s11060-013-1236-x

M3 - Article

C2 - 24005771

AN - SCOPUS:84890254848

VL - 115

SP - 353

EP - 363

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -